In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis

dc.creatorSilva, Dahara Keyse Carvalho
dc.creatorTeixeira, Jessicada Silva
dc.creatorMoreira, Diogo Rodrigo Magalhães
dc.creatorSilva, Tiago Fernandes da
dc.creatorBarreiro, Eliezer Jesus de Lacerda
dc.creatorFreitas, Humberto Fonseca de
dc.creatorPita, Samuel Silva da Rocha
dc.creatorTeles, André Lacerda Braga
dc.creatorGuimarães, Elisalva Teixeira
dc.creatorSoares, Milena Botelho Pereira
dc.date.accessioned2021-02-16T13:24:54Z
dc.date.accessioned2023-09-05T16:14:18Z
dc.date.available2021-02-16T13:24:54Z
dc.date.available2023-09-05T16:14:18Z
dc.date.created2021-02-16T13:24:54Z
dc.date.issued2020
dc.identifierSILVA, Dahara Keyse Carvalho et al. In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis. Frontiers in Pharmacology, v. 11, p. 1-14, 2020.
dc.identifier1663-9812
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/46085
dc.identifier10.3389/fphar.2020.590544
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8675971
dc.languageeng
dc.publisherFrontiers Media
dc.rightsopen access
dc.titleIn Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis
dc.typeArticle


Este ítem pertenece a la siguiente institución